Taken together, our studies show that MYADM is a novel association partner for SP-A on eosinophils that is necessary for SP-A to induce eosinophil apoptosis and we bring to light the potential importance of this previously unrecognized transmembrane receptor in patients with asthma. Here, SFTPA2 is linked to asthma.